BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38583892)

  • 1. Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis.
    Li W; Ren H; Mou H; Li J; Dong L; Li G; Xing M
    J Gastrointest Surg; 2024 Apr; 28(4):425-433. PubMed ID: 38583892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
    Jeon Y; Park EJ; Lim JH; Baik SH
    World J Surg Oncol; 2019 Dec; 17(1):214. PubMed ID: 31829188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    An SL; Ji ZH; Li XB; Liu G; Zhang YB; Gao C; Zhang K; Zhang XJ; Yan GJ; Yan LJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):434-441. PubMed ID: 37217351
    [No Abstract]   [Full Text] [Related]  

  • 4. Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence.
    Grange R; Rousset P; Williet N; Guesnon M; Milot L; Passot G; Phelip JM; Le Roy B; Glehen O; Kepenekian V
    Ann Surg Oncol; 2024 Apr; 31(4):2378-2390. PubMed ID: 38170409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.
    Flood MP; Das AA; Soucisse ML; Kong J; Ramsay RG; Michael M; Loveday BPT; Warrier SK; Heriot AG
    Dis Colon Rectum; 2021 Jun; 64(6):754-764. PubMed ID: 33742615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases.
    Ito K; Takemura N; Inagaki F; Mihara F; Kurokawa T; Gohda Y; Kiyomatsu T; Yano H; Kokudo N
    World J Surg Oncol; 2019 Jun; 17(1):99. PubMed ID: 31196097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
    Shida D; Tsukamoto S; Ochiai H; Kanemitsu Y
    Ann Surg Oncol; 2018 Jan; 25(1):173-178. PubMed ID: 29063295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of hyperthermic intraperitoneal chemotherapy in gastric cancer with synchronous peritoneal metastases: a real-world retrospective study.
    Guo J; Deng Z; Jin L; Yin S; Xiong Z; Wang C; Chen H; Luo D; Huang D; Peng J; Chen S; Lian L
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17881-17896. PubMed ID: 37947869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases.
    Wach MM; Nunns G; Hamed A; Derby J; Jelinek M; Tatsuoka C; Holtzman MP; Zureikat AH; Bartlett DL; Ahrendt SA; Pingpank JF; Choudry MHA; Ongchin M
    Ann Surg Oncol; 2024 Apr; 31(4):2391-2400. PubMed ID: 38270826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
    Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus R0 resection for resectable colorectal cancer with peritoneal metastases and low peritoneal cancer index scores: a collaborative observational study from Korea and Japan.
    Kitaguchi D; Park EJ; Baik SH; Sasaki S; Tsukada Y; Ito M
    Int J Surg; 2024 Jan; 110(1):45-52. PubMed ID: 37800569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy.
    Zhou S; Jiang Y; Liang J; Pei W; Zhou Z
    World J Surg Oncol; 2021 May; 19(1):151. PubMed ID: 34001125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following synchronous liver resection, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: A bi-institutional study.
    Flood MP; Waters PS; Kelly ME; Shields C; Conneely J; Ramsay R; Michael M; Loveday B; Warrier SK; Mulsow J; Heriot AG
    Surg Oncol; 2021 Jun; 37():101553. PubMed ID: 33839444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of laparoscopic hyperthermic intraperitoneal perfusion chemotherapy combined with intraperitoneal and systemic chemotherapy treatment in patients with untreated gastric cancer with peritoneal metastasis].
    Li S; Xue K; Dai HM; Wang YK; Shan F; Li ZY; Ji JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):442-447. PubMed ID: 37217352
    [No Abstract]   [Full Text] [Related]  

  • 15. Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery?
    Delhorme JB; Dupont-Kazma L; Addeo P; Lefebvre F; Triki E; Romain B; Meyer N; Bachellier P; Rohr S; Brigand C
    Int J Surg; 2016 Jan; 25():98-105. PubMed ID: 26607853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Blackham AU; Russell GB; Stewart JH; Votanopoulos K; Levine EA; Shen P
    Ann Surg Oncol; 2014 Aug; 21(8):2667-74. PubMed ID: 24615177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
    Quénet F; Elias D; Roca L; Goéré D; Ghouti L; Pocard M; Facy O; Arvieux C; Lorimier G; Pezet D; Marchal F; Loi V; Meeus P; Juzyna B; de Forges H; Paineau J; Glehen O;
    Lancet Oncol; 2021 Feb; 22(2):256-266. PubMed ID: 33476595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.
    Adileh M; Mor E; Assaf D; Benvenisti H; Laks S; Ben-Yaacov A; Schtrechman G; Hazzan D; Shacham-Shmueli E; Margalit O; Halpern N; Aderka D; Perelson D; Ariche A; Nissan A
    Ann Surg Oncol; 2021 Jun; 28(6):3320-3329. PubMed ID: 32968959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration combined with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for advanced primary or recurrent colorectal cancer with peritoneal metastases.
    Brown KGM; Ansari N; Solomon MJ; Austin KKS; Hamilton AER; Young CJ
    Colorectal Dis; 2021 Jan; 23(1):186-191. PubMed ID: 32978813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.